Neuroprotective and Symptomatic Effects of Cannabidiol in an Animal Model of Parkinson’s Disease

Parkinson’s disease (PD) is a neurodegenerative disorder characterized by the loss of dopaminergic neurons in the Substantia Nigra pars compacta, leading to classical PD motor symptoms. Current therapies are purely symptomatic and do not modify disease progression. Cannabidiol (CBD), one of the main...

Descripción completa

Detalles Bibliográficos
Autores principales: Giuliano, Claudio, Francavilla, Miriam, Ongari, Gerardo, Petese, Alessandro, Ghezzi, Cristina, Rossini, Nora, Blandini, Fabio, Cerri, Silvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396349/
https://www.ncbi.nlm.nih.gov/pubmed/34445626
http://dx.doi.org/10.3390/ijms22168920

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396349/
https://www.ncbi.nlm.nih.gov/pubmed/34445626
http://dx.doi.org/10.3390/ijms22168920

Ejemplares similares